LEADER 04576nam 2200565 450 001 9910798004803321 005 20230807211442.0 010 $a92-893-4194-7 010 $a92-893-4193-9 035 $a(CKB)3710000000605362 035 $a(EBL)4453391 035 $a(MiAaPQ)EBC4453391 035 $a(Au-PeEL)EBL4453391 035 $a(CaPaEBR)ebr11227855 035 $a(OCoLC)946552929 035 $a(EXLCZ)993710000000605362 100 $a20160714h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aWorking hours and health - 2014 $ecoordination of research on working hours and health in the Nordic countries - future perspectives 2014 /$fA. D. Larsen [and twenty seven others] 210 1$aCopenhagen, [Denmark] :$cNordic Council of Ministers,$d2015. 210 4$dİ2015 215 $a1 online resource (81 p.) 225 1 $aTemaNord,$x0908-6692 ;$v2015:543 300 $aDescription based upon print version of record. 311 $a92-893-4192-0 320 $aIncludes bibliographical references. 327 $aContents; Summary; Introduction; 1. Scope and program of the work-shop "Coordination of research on working hours and health in the Nordic countries" in 2014; 2. Participants; Finland; Norway; Sweden; Denmark; Norway; Sweden; Iceland; Denmark; 3. Future collaborations; 3.1 Future meetings and funding; 4. Identification of key variables on working hours; 5. Identification of relevant registers on health outcomes across the Nordic countries; 5.1 Finland; 1. Hospitalizations; 2. Sickness absence; 3. Prescription drugs; 4. Cancer; 5. Accidents; 6. Pensions; 7. Mortality; 5.2 Norway 327 $a1. Hospitalizations2. Sickness absence; 3. Prescription drugs; 4. Cancer; 5. Accidents; 6. Military; 7. Cause of Death; 8. Diabetes; 5.2.1 Demographic; 9. Education; 10. Tax; 5.3 Sweden; 1. Hospitalizations; 2. Sickness absence; 3. Prescription drugs; 4. Cancer; 5. Accidents; 5.4 Denmark; 1. Hospitalizations; 2. Sickness absence; 3. Prescription drugs; 4. Cancer; 5. Accidents; 6. Causes of Death; 7. Pension; 6. Abstracts; 6.1 Which groups are characterised by high or low work time control? A study in progress; Stress Research Institute Stockholm University 327 $a6.2 Research needs in the field of working hours and reproductive healthDepartment of Occupational and Environmental Medicine, Bispebjerg hospital and University of Copenhagen; References; 6.3 How do different definitions of night shift affect the exposure assessment of night work?; References; 6.4 A comparison of information on working time from self-reports and pay-roll data - an example from Denmark; 6.5 Number of consecutive nights and sleep; References; 6.6 A Register Study Examining the Association between Shift Work and Sickness Absence 327 $a6.7 Developing measures to objectively assess working time patterns relevant to healthThe Finnish Institute of Occupational Health, Helsinki, Finland; 6.8 Nonpharmacological treatments of insomnia among shift workers; Development of Work and Organizations, Finnish Institute of Occupational Health; References; 6.9 Overview of on-going working time research projects at the Stress Research Institute; 6.10 The SLOSH cohort - with emphasizes on work time related measures; Stress Research Institute, Stockholm University, Sweden. 327 $a6.11 Studies of health outcome and sick leave, based on survey data from Statistics NorwayNational Institute of Occupational Health, Norway; 6.12 Importance of natural daylight exposure in healthy shiftwork; Stress Research Institute, Stockholm University, Sweden, arne.lowden@su.se; 6.13 Hyperalgesia after experimental and work-related sleep restriction; 6.14 Working hours and accidents; The National Research Centre for the Working Environment, Denmark; 6.15 Sleep, sleepiness, and sleepiness countermeasures in safety-critical industries: field studies on truck drivers and airline pilots 327 $aFinnish Institute of Occupational Health, Helsinki, Finland 410 0$aTemaNord ;$v2015:543. 606 $aHours of labor$xLaw and legislation 606 $aHours of labor$vCross-cultural studies 615 0$aHours of labor$xLaw and legislation. 615 0$aHours of labor 676 $a344.012572 702 $aLarsen$b A. D. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910798004803321 996 $aWorking hours and health - 2014$93727740 997 $aUNINA LEADER 05258nam 2200637 a 450 001 9910813686203321 005 20240313151530.0 010 $a1-118-53807-2 010 $a1-299-25257-5 010 $a1-118-52217-6 035 $a(CKB)2560000000098231 035 $a(EBL)1129734 035 $a(OCoLC)830169159 035 $a(SSID)ssj0000831972 035 $a(PQKBManifestationID)11476909 035 $a(PQKBTitleCode)TC0000831972 035 $a(PQKBWorkID)10882194 035 $a(PQKB)10515311 035 $a(MiAaPQ)EBC1129734 035 $a(Au-PeEL)EBL1129734 035 $a(CaPaEBR)ebr10662567 035 $a(CaONFJC)MIL456507 035 $a(EXLCZ)992560000000098231 100 $a20130308d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aOocyte physiology and development in domestic animals /$fedited by Rebecca L. Krisher 205 $a1st ed. 210 $aAmes, Iowa $cWiley-Blackwell$d2013 215 $a1 online resource (261 p.) 300 $aDescription based upon print version of record. 311 $a0-470-95920-7 320 $aIncludes bibliographical references and index. 327 $aOocyte Physiology and Development in Domestic Animals; Contents; Contributors; Preface; Acknowledgments; 1 Oocyte Development before and during Folliculogenesis; 1.1 Introduction; 1.2 Germ Cell Cyst and Ovigerous Cord Formation; 1.3 Meiotic Entry and Progression; 1.4 Follicle Formation; 1.5 Follicle Development; 1.6 Steroid Hormone Signaling in Oocyte Development; 1.7 Summary; References; 2 The In Vitro Culture of Ovarian Follicles: A Brief History and Current Considerations; 2.1 Introduction; 2.1.1 Ovarian Follicles; 2.1.2 Follicle Culture and Fertility Preservation 327 $a2.2 A Brief Historical Review of In Vitro Follicle Culture2.3 State-of-the-Art In Vitro Follicle Culture; 2.3.1 Alternative and Complementary Strategies; 2.4 The Future of Ovarian Follicle Culture; Acknowledgments; References; 3 Regulation of Oocyte Meiotic Resumption by Somatic Cells; 3.1 Meiotic Resumption Is Negatively Regulated in a cAMP-Dependent Manner; 3.2 The Regulation of cAMP Level in Mouse Oocytes; 3.3 The Expression and Roles of PDEs in both Cumulus Cells and Oocytes in Domestic Animals concentration; 3.4 Closure of Gap Junctional Communication 327 $a3.5 How to Activate the ERK1/2 Pathway in Cumulus Cells of COC3.6 ERK1/2 in Cumulus Cells Is Required for Meiotic Resumption; 3.7 Dynamic Changes of Kinase Activities within Oocytes; 3.8 Conclusion; References; 4 Oocyte-Secreted Factors in Domestic Animals; 4.1 Introduction; 4.2 Historical Background; 4.3 Localization and Specificity; 4.3.1 TGF? Superfamily; 4.3.2 Fibroblast Growth Factors; 4.4 Structure and Genetic Diversity of Gdf9 and Bmp15; 4.5 Signalling Mechanisms of Gdf9 and Bmp15; 4.6 Roles of Oocyte-Secreted Factors; 4.6.1 Follicle Growth, Cell Proliferation, and Apoptosis 327 $a4.6.2 Regulation of Steroidogenesis and Luteinization4.6.3 Cumulus Cell Expansion; 4.6.4 Cumulus Cell Metabolism; 4.7 Manipulation and Use in Reproductive Technologies; 4.7.1 Altering Ovulation Rate-Antibodies; 4.7.2 In Vitro Embryo Production; 4.8 Concluding Remarks; References; 5 MicroRNAs in Oocyte Physiology and Development; 5.1 Introduction; 5.2 Biogenesis of miRNA; 5.3 Recognition and Post-Transcriptional Regulation of Target mRNA by miRNA; 5.4 miRNA in Germ Cell Differentiation and Oogenesis; 5.5 Expression and Regulation of miRNA in Oocyte Development 327 $a5.6 miRNAs in Oocyte Maturation and Competence5.7 miRNAs as Temporal Regulatory Cascades of Maternal mRNA Translation; 5.8 miRNAs in Oocyte Development in Relation to Endocrine Control; 5.9 miRNA Regulation of Epigenetic Mechanisms in the Oocyte; 5.10 Strategic Approaches and Challenges to Study the Role of miRNAs in Oocytes; 5.11 Concluding Remarks; References; 6 Bovine Oocyte Gene Expression: Identification of Functional Regulators of Early Embryogenesis; 6.1 Introduction 327 $a6.2 Potential Contribution of Oocyte-Specific Transcriptional and Post-Transcriptional Regulators to Bovine Oocyte Competence: Available Evidence and Gaps in Knowledge 330 $aOocyte Physiology and Development in Domestic Animals reviews the most recent advances in the research of physiological and biochemical mechanisms underlying oocyte growth and development, providing readers with the fundamental understanding of these key processes and summarizing this important field of research. The book covers multiple molecular and physiological mechanisms including initiation of oocyte growth during folliculogenesis and in vitro follicle culture to support oocyte competence, that are critical to health and quality. Physiological process ranging from gene expression 606 $aOvum 606 $aDomestic animals$xEmbryology 615 0$aOvum. 615 0$aDomestic animals$xEmbryology. 676 $a573.68 701 $aKrisher$b Rebecca L$01671132 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910813686203321 996 $aOocyte physiology and development in domestic animals$94033479 997 $aUNINA